ArticleTargeted oncology2019

Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib.

Chih-Hsi Scott Kuo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.